ML23151A615

From kanterella
Revision as of 12:56, 14 November 2024 by StriderTol (talk | contribs) (StriderTol Bot change)
Jump to navigation Jump to search
May 4, 2023 Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Proprietary Meeting Information - Affidavit
ML23151A615
Person / Time
Issue date: 06/05/2023
From: Meginnis A
Licensing Processes Branch
To: Ngola Otto
Licensing Processes Branch
References
ANP-10339P, Revision 0
Download: ML23151A615 (1)


Text

A F F I D A V I T

1. My name is Alan B. Meginnis. I am Manager, Product Licensing, for

Framatome Inc. and as such I am authorized to execute this Affidavit.

2. I am familiar with the criteria applied by Framatome to determine whether

certain Framatome information is proprietary. I am familiar with the policies established by

Framatome to ensure the proper application of these criteria.

3. I am familiar with the Framatome information contained in the file named

Fz_sampling_resp_round2.pdf dated May 2023 and referred to herein as Document.

Information contained in this Document has been classified by Framatome as proprietary in

accordance with the policies established by Framatome for the control and protection of

proprietary and confidential information.

4. This Document contains information of a proprietary and confidential nature

and is of the type customarily held in confidence by Framatome and not made available to the

public. Based on my experience, I am aware that other companies regard information of the

kind contained in this Document as proprietary and confidential.

5. This Document has been made available to the U.S. Nuclear Regulatory

Commission in confidence with the request that the information contained in this Document be

withheld from public disclosure. The request for withholding of proprietary information is made

in accordance with 10 CFR 2.390. The information for which withholding from disclosure is

requested qualifies under 10 CFR 2.390(a)(4) Trade secrets and commercial or financial

information.

6. The following criteria are customarily applied by Framatome to determine

whether information should be classified as proprietary:

(a) The information reveals details of Framatome s research and development

plans and programs or their results.

(b) Use of the information by a competitor would permit the competitor to

significantly reduce its expenditures, in time or resources, to design, produce,

or market a similar product or service.

(c) The information includes test data or analytical techniques concerning a

process, methodology, or component, the application of which results in a

competitive advantage for Framatome.

(d) The information reveals certain distinguishing aspects of a process,

methodology, or component, the exclusive use of which provides a

competitive advantage for Framatome in product optimization or marketability.

(e) The information is vital to a competitive advantage held by Framatome, would

be helpful to competitors to Framatome, and would likely cause substantial

harm to the competitive position of Framatome.

The information in the Document is considered proprietary for the reasons set forth in

paragraphs 6(a), 6(b), 6(d), 6(c), 6(d) and 6(e) above.

7. In accordance with Framatomes policies governing the protection and control

of information, proprietary information contained in this Document have been made available,

on a limited basis, to others outside Frama tome only as required and under suitable agreement

providing for nondisclosure and limited use of the information.

8. Framatome policy requires that proprietary information be kept in a secured

file or area and distributed on a need-to-know basis.

9. The foregoing statements are true and correct to the best of my knowledge,

information, and belief.

I declare under penalty of perjury that the foregoing is true and correct.

Executed on: May 17, 2023

Alan B. Meginnis